Flora Sheng

451 total citations
24 papers, 273 citations indexed

About

Flora Sheng is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and General Health Professions. According to data from OpenAlex, Flora Sheng has authored 24 papers receiving a total of 273 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Public Health, Environmental and Occupational Health, 8 papers in Epidemiology and 5 papers in General Health Professions. Recurrent topics in Flora Sheng's work include Opioid Use Disorder Treatment (12 papers), Substance Abuse Treatment and Outcomes (7 papers) and Pain Management and Opioid Use (5 papers). Flora Sheng is often cited by papers focused on Opioid Use Disorder Treatment (12 papers), Substance Abuse Treatment and Outcomes (7 papers) and Pain Management and Opioid Use (5 papers). Flora Sheng collaborates with scholars based in United States, China and Switzerland. Flora Sheng's co-authors include Bradley D. Stein, Mark Sorbero, Jesus Maria Garcia Calleja, Bernard F. Fuemmeler, Ryuichi Komatsu, Keith Sabin, Jinkou Zhao, David Powell, Andrew W. Dick and Susan K. Murphy and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of the American Geriatrics Society.

In The Last Decade

Flora Sheng

22 papers receiving 265 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Flora Sheng United States 11 117 102 57 51 47 24 273
Antoinette L. Spector United States 10 99 0.8× 106 1.0× 35 0.6× 49 1.0× 78 1.7× 26 278
Joel J. Earlywine United States 9 182 1.6× 197 1.9× 68 1.2× 28 0.5× 57 1.2× 17 309
James Fetherston Australia 9 170 1.5× 271 2.7× 46 0.8× 52 1.0× 53 1.1× 13 424
Lauretta Cathers United States 5 111 0.9× 117 1.1× 31 0.5× 28 0.5× 64 1.4× 9 267
Natasha Underwood United States 9 113 1.0× 190 1.9× 43 0.8× 24 0.5× 20 0.4× 17 297
Julia Zur United States 9 125 1.1× 151 1.5× 55 1.0× 26 0.5× 133 2.8× 24 353
Maria Bolshakova United States 12 77 0.7× 54 0.5× 56 1.0× 26 0.5× 56 1.2× 28 294
Jenny Keen United Kingdom 11 191 1.6× 224 2.2× 51 0.9× 32 0.6× 55 1.2× 20 339
Michelle Pang Canada 8 214 1.8× 153 1.5× 89 1.6× 39 0.8× 54 1.1× 14 319
Anna Pecoraro United States 13 172 1.5× 276 2.7× 62 1.1× 27 0.5× 79 1.7× 18 449

Countries citing papers authored by Flora Sheng

Since Specialization
Citations

This map shows the geographic impact of Flora Sheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Flora Sheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Flora Sheng more than expected).

Fields of papers citing papers by Flora Sheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Flora Sheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Flora Sheng. The network helps show where Flora Sheng may publish in the future.

Co-authorship network of co-authors of Flora Sheng

This figure shows the co-authorship network connecting the top 25 collaborators of Flora Sheng. A scholar is included among the top collaborators of Flora Sheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Flora Sheng. Flora Sheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sheng, Flora, et al.. (2025). Cross-sectional examination of characteristics of higher-dose buprenorphine prescriptions during the era of illicit fentanyl. Addiction Science & Clinical Practice. 20(1). 33–33.
2.
3.
Pacula, Rosalie Liccardo, Beth Ann Griffin, Megan S. Schuler, et al.. (2025). Improving Policy Evaluations Of The Opioid Crisis. Health Affairs. 44(9). 1042–1049. 1 indexed citations
4.
Ernecoff, Natalie C., et al.. (2024). Buprenorphine prescribing practices for older adults in 2019 and 2020. Journal of the American Geriatrics Society. 73(4). 1204–1209. 1 indexed citations
5.
Schulson, Lucy, Andrew W. Dick, Flora Sheng, & Bradley D. Stein. (2023). An Exploratory Analysis of Differential Prescribing of High-Risk Opioids by Insurance Type Among Patients Seen by the Same Clinician. Journal of General Internal Medicine. 38(7). 1681–1688. 1 indexed citations
6.
Sheng, Flora, Andrew W. Dick, Mark Sorbero, et al.. (2023). Differences in medicaid expansion effects on buprenorphine treatment utilization by county rurality and income: A pharmacy data claims analysis from 2009–2018. SHILAP Revista de lepidopterología. 9. 100193–100193. 2 indexed citations
7.
Stein, Bradley D., Brendan Saloner, Barbara Andraka‐Christou, et al.. (2023). Association of Selected State Policies and Requirements for Buprenorphine Treatment With Per Capita Months of Treatment. JAMA Health Forum. 4(5). e231102–e231102. 14 indexed citations
8.
Stein, Bradley D., Flora Sheng, Brendan Saloner, et al.. (2022). Buprenorphine Treatment Episodes During the First Year of COVID: a Retrospective Examination of Treatment Initiation and Retention. Journal of General Internal Medicine. 38(3). 733–737. 11 indexed citations
9.
Fuemmeler, Bernard F., Julia C. Schechter, Rachel L. Maguire, et al.. (2022). Prenatal and Childhood Smoke Exposure Associations with Cognition, Language, and Attention-Deficit/Hyperactivity Disorder. The Journal of Pediatrics. 256. 77–84.e1. 5 indexed citations
10.
Peet, Evan D., et al.. (2022). Trends in the Concurrent Prescription of Opioids and Gabapentin in the US, 2006 to 2018. JAMA Internal Medicine. 183(2). 162–162. 24 indexed citations
11.
Stein, Bradley D., Rosanna Smart, Christopher M. Jones, et al.. (2021). Individual and Community Factors Associated with Naloxone Co-prescribing Among Long-term Opioid Patients: a Retrospective Analysis. Journal of General Internal Medicine. 36(10). 2952–2957. 21 indexed citations
12.
Stein, Bradley D., Christopher M. Jones, Rosanna Smart, Flora Sheng, & Mark Sorbero. (2021). Patient, prescriber, and Community factors associated with filled naloxone prescriptions among patients receiving buprenorphine 2017-18. Drug and Alcohol Dependence. 221. 108569–108569. 10 indexed citations
13.
Stein, Bradley D., Flora Sheng, Erin Audrey Taylor, et al.. (2021). The effect of state policies on rates of high-risk prescribing of an initial opioid analgesic. Drug and Alcohol Dependence. 231. 109232–109232. 12 indexed citations
14.
Fuemmeler, Bernard F., Flora Sheng, K. Elizabeth, et al.. (2020). Mila Blooms: A Mobile Phone Application and Behavioral Intervention for Promoting Physical Activity and a Healthy Diet Among Adolescent Survivors of Childhood Cancer. Games for Health Journal. 9(4). 279–289. 26 indexed citations
15.
Damberg, Cheryl L., et al.. (2020). Simplified Notifications Improve Response Rates to Patient Surveys: Findings from the Medicare Disenrollment Survey Experiment. Health Services Research. 55(S1). 108–108. 2 indexed citations
16.
Barnes, Andrew J., et al.. (2020). Hospital Use Declines After Implementation Of Virginia Medicaid’s Addiction And Recovery Treatment Services. Health Affairs. 39(2). 238–246. 8 indexed citations
17.
Fuemmeler, Bernard F., Nancy Zucker, Flora Sheng, et al.. (2019). Pre-Pregnancy Weight and Symptoms of Attention Deficit Hyperactivity Disorder and Executive Functioning Behaviors in Preschool Children. International Journal of Environmental Research and Public Health. 16(4). 667–667. 27 indexed citations
18.
Cunningham, Peter & Flora Sheng. (2018). Trends in Preventable Inpatient and Emergency Department Utilization in California Between 2012 and 2015. Medical Care. 56(6). 544–550. 10 indexed citations
19.
20.
Li, Hui, Yu Chen, Bin Zhou, et al.. (2011). Polymorphisms of presenilin-1 gene associate with dilated cardiomyopathy susceptibility. Molecular and Cellular Biochemistry. 358(1-2). 31–36. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Antoinette L. Spector Breakdown of academic impact, for papers by Joel J. Earlywine Breakdown of academic impact, for papers by James Fetherston Breakdown of academic impact, for papers by Lauretta Cathers Breakdown of academic impact, for papers by Natasha Underwood Breakdown of academic impact, for papers by Julia Zur Breakdown of academic impact, for papers by Maria Bolshakova Breakdown of academic impact, for papers by Jenny Keen Breakdown of academic impact, for papers by Michelle Pang Breakdown of academic impact, for papers by Anna Pecoraro
Rankless by CCL
2026